• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Withdrawal of sibutramine in Europe.

作者信息

Williams Gareth

出版信息

BMJ. 2010 Feb 9;340:c824. doi: 10.1136/bmj.c824.

DOI:10.1136/bmj.c824
PMID:20144986
Abstract
摘要

相似文献

1
Withdrawal of sibutramine in Europe.西布曲明在欧洲的撤市
BMJ. 2010 Feb 9;340:c824. doi: 10.1136/bmj.c824.
2
European Medicines Agency withdrawal for sibutramine.欧洲药品管理局撤销西布曲明（的上市许可）。
Arch Dis Child. 2010 Oct;95(10):856. doi: 10.1136/adc.2010.190959. Epub 2010 Jun 23.
3
Withdrawal of sibutramine leaves European doctors with just one obesity drug.西布曲明退市后，欧洲医生只剩下一种治疗肥胖症的药物。
BMJ. 2010 Jan 25;340:c477. doi: 10.1136/bmj.c477.
4
Sibutramine (Meridia) withdrawn.西布曲明（曲美）已撤市。
Med Lett Drugs Ther. 2010 Nov 1;52(1350):88.
5
[The trial that killed a drug].[那场让一种药物夭折的试验]
Lakartidningen. 2010;107(39):2339.
6
Sibutramine--another flawed diet pill.西布曲明——又一种有缺陷的减肥药。
N Engl J Med. 2010 Sep 2;363(10):972-4. doi: 10.1056/NEJMe1007993.
7
Sibutramine: balancing weight loss benefit and possible cardiovascular risk.
Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):337-41. doi: 10.1016/j.numecd.2008.03.008. Epub 2008 May 27.
8
Weight-loss drug fattens heart risks.
Consum Rep. 2003 Dec;68(12):57.
9
Withdrawal of sibutramine. Editorial is judgment in advance of the facts.西布曲明的撤市。编者按是在事实之前做出的判断。
BMJ. 2010 Mar 10;340:c1346. doi: 10.1136/bmj.c1346.
10
Withdrawal of sibutramine. Magic bullets now uncontrolled.
BMJ. 2010 Mar 10;340:c1351. doi: 10.1136/bmj.c1351.

引用本文的文献

1
The evolution of the understanding of obesity over the last 100 years.过去100年里对肥胖认识的演变。
Int J Obes (Lond). 2025 Feb;49(2):168-176. doi: 10.1038/s41366-024-01668-3. Epub 2024 Nov 7.
2
Appetite Suppressing Activity of Rumex Usambarensis Leaf and Stem Aqueous Extract in Wistar Albino Female Rats: an in vivo Experimental Study.乌桑巴拉酸模叶和茎水提取物对Wistar白化雌性大鼠的食欲抑制活性：一项体内实验研究。
J Exp Pharmacol. 2024 May 10;16:201-209. doi: 10.2147/JEP.S458705. eCollection 2024.
3
Colorimetric and Reverse Fluorescence Dual-Signal Readout Immunochromatographic Assay for the Sensitive Determination of Sibutramine.
用于灵敏测定西布曲明的比色和反向荧光双信号读出免疫层析测定法。
ACS Omega. 2024 Feb 2;9(6):7075-7084. doi: 10.1021/acsomega.3c09050. eCollection 2024 Feb 13.
4
Lifestyle and Pharmacological Interventions and Treatment Indications for the Management of Obesity in Children and Adolescents.儿童和青少年肥胖管理的生活方式及药物干预与治疗指征
Children (Basel). 2023 Jul 17;10(7):1230. doi: 10.3390/children10071230.
5
Obesity management: Attitudes and practice of Italian endocrinologists.肥胖管理：意大利内分泌学家的态度和实践。
Front Endocrinol (Lausanne). 2023 Jan 17;13:1061511. doi: 10.3389/fendo.2022.1061511. eCollection 2022.
6
Dietary Supplements as Source of Unintentional Doping.膳食补充剂作为非故意兴奋剂的来源。
Biomed Res Int. 2022 Apr 22;2022:8387271. doi: 10.1155/2022/8387271. eCollection 2022.
7
Looking for Crumbs in the Obesity Forest: Anti-obesity Interventions and Obesity-Associated Cardiometabolic Traits in the Mexican Population. History and Systematic Review With Meta-Analyses.在肥胖的森林中寻找线索：墨西哥人群中的抗肥胖干预措施与肥胖相关的心血管代谢特征。历史回顾与荟萃分析的系统评价
Front Med (Lausanne). 2021 Nov 3;8:665023. doi: 10.3389/fmed.2021.665023. eCollection 2021.
8
A Systematic Review of the European Rapid Alert System for Food and Feed: Tendencies in Illegal Food Supplements for Weight Loss.欧洲食品和饲料快速预警系统的系统评价：非法减肥食品补充剂的趋势
Front Pharmacol. 2021 Jan 26;11:611361. doi: 10.3389/fphar.2020.611361. eCollection 2020.
9
Systematic assessment of prescribed medications and short-term risk of myocardial infarction - a pharmacopeia-wide association study from Norway and Sweden.系统评估处方药物与心肌梗死短期风险的相关性——来自挪威和瑞典的药物学范围关联性研究。
Sci Rep. 2019 Jun 4;9(1):8257. doi: 10.1038/s41598-019-44641-1.
10
Translating the dose response into risk and benefit.将剂量反应转化为风险和收益。
Br J Clin Pharmacol. 2019 Oct;85(10):2187-2193. doi: 10.1111/bcp.13949. Epub 2019 May 17.